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Vasopressinergic (VP) neurons in the bed nucleus of the 
stria terminalis (BNST) of the rat are regulated by gonadal 
steroids. Gonadectomy causes the projections of the BNST 
to lose their VP immunoreactivity gradually over a period 
lasting more than 2 months. Here we have compared the rate 
of decline of VP mRNA and VP immunoreactivity in the BNST 
of adult male rats following castration. In experiment 1, the 
peak number of VP-immunoreactive cells and the level of 
VP gene expression were compared in sham-operated con- 
trols and at 1, 3, or 8 weeks postcastration. The number of 
VP-immunoreactive cells was not decreased at 1 week post- 
castration but was significantly reduced (p < 0.0001) at 3 
and 8 weeks postcastration. VP gene expression declined 
more rapidly, and both the total number of labeled cells (p 
< 0.0001) and the average number of grains per cell (p < 
0.01) were significantly reduced by 1 week postcastration. 
No VP-expressing cells were detectable at 3 or 8 weeks. 
The difference in the rate of decline in the number of cells 
labeled by the two techniques following castration did not 
appear to be due to colchicine pretreatment. In experiment 
2, VP mRNA in the BNST was compared in sham-operated 
controls or at 1, 3, or 7 d postcastration. A significant de- 
crease (p < 0.01) in the average number of grains per cell 
was detectable by just 1 d following castration, and the 
number of labeled cells was significantly reduced (p < 0.001) 
by 3 d postcastration. These results indicate that the ca- 
pacity of BNST cells to synthesize VP responds more dy- 
namically to changes in gonadal steroid levels than do levels 
of VP immunoreactivity. This difference may reflect the delay 
between VP gene expression and the processing of VP pre- 
cursor molecules. Alternatively, gonadal steroids may mod- 
ulate the release of VP from cells in the BNST. 
Gonadal steroids influence brain physiology and behavior by 
targeting specific neuronal systems (McEwen and Parsons, 1982). 
Vasopressin (VP) cells in the bed nucleus of the stria terminalis 
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(BNST) appear to be a prime target of gonadal steroid actions. 
In rats, these neurons are sexually dimorphic. Male rats have 
more neurons in the BNST that express VP mRNA (Miller et 
al., 1989~) or can be stained immunocytochemically for VP (Van 
Leeuwen et al., 1985) than female rats. In addition, the VP- 
immunoreactive projections of these neurons to the septum are 
denser in males than in females (De Vries et al., 1981, 1983). 
Gonadal steroids appear to influence the development of these 
pathways in the early postnatal period (De Vries et al., 1983) 
and act to maintain the pathways in adulthood (De Vries et al., 
1984, 1985, 1986). Castration of adult male rats results in the 
disappearance of VP-immunoreactive cells in the BNST (Van 
Leeuwen et al., 1985) and immunoreactive fibers in the septum 
(De Vries et al., 1984, 1985), although the time course is ex- 
tremely slow. Approximately 8-l 2 weeks are needed following 
castration for the complete disappearance of VP-immunoreac- 
tive fibers in the septum (De Vries et al., 1984). While VP- 
expressing cells in the BNST also disappear following castration 
(Miller et al., 1989b), the time course of the effects of gonadal 
steroid removal on VPgene expression has yet to be determined. 
In this study, we have compared the decline over time of VP 
mRNA levels and VP immunoreactivity of cells in the BNST 
following castration. 
Materials and Methods 
Subjects and general protocol 
Experiment 1. Intact male Wistar rats (90 d old) were obtained from 
Charles River Labs (Wilmington, MA) and were maintained under a 
12 hr light/l 2 hr dark cycle. Food and water were available ad libitum. 
Animals were killed as sham-operated controls or at 1, 3, or 8 weeks 
postcastration. Sham-operated controls were killed 1 week postsurgery. 
All of the animals for immunocytochemistry and some of the sham- 
operated controls for in situ hybridization were treated with colchicine 
(35 pg, i.c.v.) 48 hr prior to death. For immunocytochemistry, rats were 
perfused through the ascending aorta with 50 ml of0.9% saline, followed 
by 5% acrolein in 0.1 M phosphate-buffered saline (pH 7.2) for 5 min 
(about 300 ml per animal). The brains were removed and sectioned at 
50 Frn on a vibratome. Sections were collected in 0.05 M Tris-HCl. For 
in situ hybridization, brains were removed following decapitation, fro- 
zen on dry ice, and sectioned at 20 pm on a cryostat. Cryostat sections 
were thaw-mounted on RNase-free gelatin-coated slides and stored at 
- 70°C prior to being hybridized. 
Experiment 2. Intact male Wistar rats (90 d old) were obtained from 
Simonsen Laboratories (Gilroy, CA) and were maintained under a 12 
hr light/l2 hr dark cycle. Food and water were available ad libitum. 
Animals were killed as sham-operated controls or at 1, 3, or 7 d postcas- 
tration. Sham-operated controls were killed 1 d postsurgery. Brains were 
collected for in situ hybridization and were processed as outlined above. 
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Figure 1. Total number ofVP-immunoreactive neurons identified uni- 
laterallv in four atlas-matched sections through the BNST. The number 
of VP-immunoreactive cells is significantly decreased by 3 weeks post- 
castration. Data are presented as the mean f  SEM. 
Immunocytochemistry 
Immunocytochemistry was performed as previously described (De Vries 
and Al-Shamma, 1990). Free-floating sections were treated with (1) 0.1% 
sodium borohydride followed by (2) 0.05 M Tris-HCl, pH 7.6 (Tris) and 
(3) 2% goat serum, 0.9% NaCl, and 0.5% Triton X-100 in Tris (Tris- 
Triton)for 15 min. Sections were incubated overnight at 4°C in anti- 
VP (ICN, Lisle, IL) diluted 1:2000 in Tris-Triton. Following incubation, 
sections were (1) rinsed in Tris-Triton for 15 min, (2) treated for 45 
min with goat anti-rabbit IgG serum (ICN) diluted 1: 150 in Tris-Triton, 
(3) rinsed for 15 min in Tris-T&on. (4) treated for 45 min with rabbit 
peroxidase-antiperoxidase serum diluted 1:300 in Tris-Triton, and (5) 
rinsed for 15 min in Tris-Triton. These second and third antibody 
incubation steps were repeated, and sections were then rinsed in 0.9% 
NaCl in Tris (Tris-NaCl) and reacted with 0.05% 3,3’-diaminobenzidine 
in Tris-NaCl with 0.01% H,O, for 20 min. After being rinsed in Tris- 
NaCl, sections were mounted on slides, air dried, and coverslipped. 
Specificity of the antiserum was verified by (1) the absence of immu- 
noreactive cells in brain sections from VP-deficient Brattleboro rats and 
(2) the absence of immunoreactive neurons in sections stained with 
antiserum that had been reacted with 50 PM VP. 
In situ hybridization 
In situ hybridization procedures were the same as previously described 
(Miller et al., 1989a). Briefly, sections were postfixed in 4% paraformal- 
dehyde, treated with 0.25% acetic anhydride, dehydrated, delipidated, 
and air dried. A 3Ssulfur-labeled oligonucleotide probe was applied, and 
sections were coverslipped. The probe used was a 48-base oligonucle- 
otide complementary to the mRNA encoding the last 16 amino acids 
of the glycopeptide portion of the VP precursor. The probe was 3’ end- 
labeled with terminal deoxynucleotidyl transferase, purified, heat de- 
natured, and diluted to 2.5 pmol/ml in hybridization buffer [50% form- 
amide. 10% dextran sulfate. 300 mM NaCl. 10 mM Tris, 1 mM EDTA, 
1 x Denhardt’s (0.02% each’BSA, Ficoll, polyvinylpyrollidone), 0.5 mg/ 
ml yeast tRNA, and 10 mM dithiothreitol] before use. Specific activities 
were estimated at 4400 Ci/mmol (experiment 1) and 5700 Ci/mmol 
(experiment 2). A 45 pl volume was applied to two brain sections per 
slide. After overnight incubation, coverslips were removed and sections 
were washed four times in 1 x SSC (150 mM NaCl, 15 mM Na citrate) 
for 15 min at 55”C, followed by two 1 hr room temperature washes in 
1 x SSC. Sections were dehydrated through a graded series of alcohols 
containing 300 mM ammonium acetate, dipped in Kodak NTB2 emul- 
sion (Eastman Kodak. Rochester, NY: diluted 1:l with 600 mM am- 
monium acetate), and’exposed for 14 d (experiment 1) or 17 d (exper- 
iment 2). Emulsion was developed in D-19 diluted 1: 1 with distilled 
water at 16°C. Sections were counterstained with cresyl violet acetate 
and coverslipped. All samples from a single experiment were run in a 
single assay. In order to increase our ability to detect low levels of VP 
gene expression, the specific activity of the probe and the exposure time 
were increased in experiment 2. 
Quantification 
For immunocytochemistry, sections through the BNST of each animal 
were anatomically matched using the stereotaxic atlas of Konig and 
Klippel(l963). VP-immunoreactive cells were identified in bright-field 
and counted on the side of colchicine injection in four sections that 
corresponded to atlas levels 6790-6570. The cells were counted inde- 
pendently by two researchers that were blind to the treatment groups. 
Data for each group is presented as the mean + SEM of the total number 
of cells observed. Groups were compared using a one-way analysis of 
variance followed by a Sheffe F test. The criterion for significance was 
set at p < 0.05. 
For in situ hybridization, sections through the BNST of each animal 
were also matched using the Konig and Klippel atlas (levels 6790-6570). 
One section at each of the four atlas levels was read blindly by a single 
experimenter. Labeled cells were identified in dark-field, and the pres- 
ence of an underlying neuron was verified using high-magnification 
bright-field microscopy. Cells were considered to be labeled ifthe signal- 
to-noise ratio of the cell was 5 or greater. The total number of cells 
found unilaterally in the four sections was determined for each animal. 
The number of grains per cell for up to 10 randomly selected cells per 
section at each of the four levels (i.e., up to 40 cells/animal) was mea- 
sured by an automated image analysis system and averaged for each 
animal. The grain-counting system consisted of a DATA Cube IVG- 
128 video acquisition board attached to an IBM AT computer. Video 
images were obtained by a Dage model 65 camera attached to an Olym- 
DUS microscope (Olvmous. New Hvde Park. NY) eCUriDDed with a 40 x _ __ 
objective and- dark:fielh condenser (see Chowen’et al., 199 1, for a de- 
tailed description of the grain counting methodology). Data are pre- 
sented as the mean + SEM. For each experiment, a one-way analysis 
of variance followed by a Sheffe test was used to assess differences 
between the groups. Criterion for significance was set at p < 0.05. 
Results 
Experiment I 
As can be seen in Figure 1, the total number of VP-immuno- 
reactive cells found unilaterally in the four sections through the 
BNST declines following castration. Although animals castrated 
for 1 week do not differ significantly from sham-operated con- 
trols (1 week: 149.5 & 20, n = 6; control: 189.4 ? 39.5, n = 
6) cell number is significantly decreased (p < 0.000 1) in animals 
castrated for 3 weeks (28.5 * 7.2, n = 5). By 8 weeks postcas- 
tration (n = 6) an average of only 13.3 * 2.8 stained cells were 
observed. Figure 2 shows low-power bright-field photomicro- 
graphs of VP-immunoreactive neurons in the BNST of a rep- 
resentative control animal (A) and animals castrated for 1 (B), 
3 (C), or 8 (II) weeks. 
The number of cells expressing VP mRNA in the BNST de- 
clines more rapidly following castration than the number of VP- 
immunoreactive cells. As shown in Figure 3, the total number 
of labeled cells found unilaterally in the four atlas-matched sec- 
tions is significantly reduced by 1 week postcastration (98.6 ? 
8 vs. 9.0 f 5.1; n = S/group). The remaining cells exhibited a 
reduced labeling intensity, with 57.2 f 3.0 versus 31.8 + 3.0 
grains/cell for controls and 1 week castrates, respectively (Fig. 
4). No VP-expressing cells were detectable at 3 or 8 weeks post- 
castration in this experiment (n = S/group). By the established 
criteria, pretreatment of sham-operated controls (n = 5) with 
colchicine did not significantly influence the number of labeled 
cells or the labeling intensity compared to untreated sham-op- 
erated controls. 
Experiment 2 
As can be seen in Figure 5, the VP mRNA levels in the BNST 
are significantly decreased by just 1 d following castration. The 
average number of grains per cell declined over time from 77.4 
* 3.1 (sham, n = 5) to 65.5 & 1.7 (1 d, n = 6), 50.5 f 2.1 (3 
d, n = 6) and 40.0 & 1 .O (7 d, n = 6). The average total number 
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Figure 2. Low-power bright-field photomicrographs of VP-immunoreactive neurons in the BNST (level 6670) of a representative sham-operated 
control animal (A) and animals castrated for 1 (II), 3 (c), and 8 weeks (0). Scale bars, 40 pm. 
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Figure 3. Total number of neurons expressing VP mRNA identified 
unilaterally in four atlas-matched sections through the BNST. The num- 
ber of labeled cells is significantly reduced by 1 week postcastration. 
Pretreatment with colchicine does not significantly affect the number 
of VP-expressing neurons. Data are presented as the mean * SEM. 
of labeled cells in the four atlas-matched sections is significantly 
reduced by 3 d following castration and further reduced by 7 d 
postcastration (Fig. 6). Signal-to-noise ratios of labeled cells 
averaged 20 in sham-operated controls and 18, 16, and 12 in 
rats castrated for 1, 3, or 7 d, respectively. Low-power dark- 
field photomicrographs of hybridized sections through the BNST 
of representative animals are shown in Figure 7. 
Discussion 
In this article, we report that VP mRNA levels in the BNST 
respond more dynamically to steroid hormone removal than 
does VP immunoreactivity. We found that VP gene expression 
in the BNST was dramatically reduced by 1 week postcastration 
whereas the number of VP-immunoreactive neurons was not 
significantly reduced until 3 weeks postcastration. In a second 
experiment, we observed that VP mRNA levels were signifi- 
cantly decreased by just 1 d following castration. The average 
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Figure 4. Average number of grains per cell expressed by VP neurons 
in BNST. At 1 week postcastration, cells had significantly fewer grains/ 
cell than did sham-operated controls. Pretreatment of sham-operated 
controls with colchicine reduced labeling intensity compared to untreat- 
ed sham-operated controls. Data are presented as the mean ? SEM. 
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Figure 5. Average number of grains per cell expressed by VP neurons 
at 1,3, and 7 d postcastration. Labeling intensity is significantly reduced 
by 1 d postcastration. Data are presented as the mean * SEM. 
labeling intensity was decreased by 15%, 35%, and 48% at 1, 3, 
and 7 d, respectively. At 3 d postcastration, a significant decline 
could also be detected in the number of cells expressing VP 
mRNA. This suggests that mRNA levels may be a more sen- 
sitive index than immunoreactivity for assessing the acute effects 
of steroid hormones on VP neurons in the BNST. 
The slower postcastration decline ofthe VP immunoreactivity 
than of VP mRNA could be due to colchicine treatment, which 
was only given to animals used for immunocytochemistry. Al- 
though early reports suggested that colchicine treatment did not 
influence gene expression (Gee and Roberts, 1983; Wolfson et 
al., 1985) recent studies have indicated that biosynthesis of 
several transmitter systems is indeed affected by colchicine and 
the direction of this effect is dependent on both the particular 
transmitter and the site of synthesis (Cortes et al., 1990). The 
differential decline of VP immunoreactivity and VP mRNA 
levels in the BNST could occur if colchicine treatment stimu- 
lated VP synthesis and increased peptide content. We assessed 
the effects of colchicine on VP synthesis by comparing mRNA 
levels in sham-operated controls with and without colchicine. 
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Figure 6. Total number of labeled cells identified unilaterally in four 
atlas-matched sections through the BNST at 1,3, and 7 d postcastration. 
The number of labeled cells is significantly reduced by 3 d following 
castration. Data are presented as the mean f  SEM. 
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Figure 7. Low-power dark-field photomicrographs of sections (atlas level 6670) hybridized for VP mRNA from a representative sham-operated 
control (A) and an animal castrated for 7 d (B). 
We found that although there was a tendency for reduced la- 
beling intensity, treatment of sham-operated controls with col- 
chicine did not significantly influence VP gene expression in the 
BNST by our criteria. Unless this tendency would be reversed 
in castrated rats, these findings suggest that the difference in the 
rate of decline of VP mRNA and immunoreactivity cannot be 
attributed to colchicine pretreatment. 
VP immunoreactivity could be dependent on several factors 
including peptide synthesis, release, and degradation. The dif- 
ference between the decline of VP mRNA levels and the more 
gradual decline of VP immunoreactivity in the BNST may re- 
flect steroid effects on any of these parameters. Peptide synthesis 
and processing in the intact animal has been shown to require 
on the order of several hours (Eipper et al., 1987). This would 
suggest that factors other than the time necessary for translation 
and processing contribute to the difference in postcastration 
decline of VP immunoreactivity and VP mRNA. However, go- 
nadal steroids may also regulate the processing of peptide pre- 
cursors and alter this expected time frame. Steroid hormones 
have been shown to influence the processing of other peptides 
by influencing the activity or levels of processing enzymes. In 
the paraventricular nucleus, glucocorticoids regulate the ex- 
pression of peptidyl-glycine cu-amidating monooxygenase (Gri- 
no et al., 1990), an enzyme involved in the processing of pre- 
propressophysin. In addition, processing of the prohormone for 
gonadotropin-releasing hormone is modified by castration (Culler 
et al., 1988). The strong staining of cell bodies observed at 1 
week postcastration indicates that VP is accumulating in the 
somata after colchicine treatment. Whether this represents de 
n~vo synthesis or posttranslational processing to immunocy- 
tochemically accessible peptide cannot be determined. The rate 
of processing of the VP precursor may also be reduced following 
castration. The availability of antibodies directed against spacer 
peptides of the prepropressophysin molecule (Verbalis et al., 
199 1) might make it possible to determine whether the rate of 
processing is reduced following castration. 
In addition to potential changes in synthesis and processing, 
VP transport may be reduced following castration. Recent stud- 
ies in the magnocellular system have reported that the transport 
of VP is linked to the rate of synthesis (Roberts et al., 199 1). If 
VP transport in extrahypothalamic cells is also linked to syn- 
thesis, then castration-induced decreases in peptide synthesis 
would be expected to result in decreases in transport as well. 
Therefore, it is conceivable that castration-dependent differ- 
ences in production, processing, and transport might all con- 
tribute to the delayed decline of VP immunoreactivity following 
castration. 
Alternatively, VP release from neurons in the BNST may be 
very low in the basal state such that previously translated pep- 
tide may remain stored within the cell and its processes for 
prolonged periods of time. Early estimates of VP disappearance 
from the neural lobe of the rat indicated a half-life of approx- 
imately 19 d (Burford and Pickering, 1973). Whether VP in 
extrahypothalamic sites disappears with a similar time course 
is not known. A slow release is a potential explanation for the 
gradual (3 month) disappearance of VP immunoreactivity from 
the terminals (De Vries et al., 1984). 
Castration may reduce VP release even further. There is at 
least indirect evidence that VP release in the ventral septum 
(presumably from neurons in the BNST) is reduced following 
castration. In intact rats, injections of pyrogens stimulate VP 
release in the septum (Cooper et al., 1979), which is linked to 
suppression of fever (Kasting, 1989). Long-term castrated rats 
show prolonged fever following challenge with a pyrogen, which 
may be related to lowered VP release (Pittman et al., 1988). No 
study has as yet evaluated the effects of short-term castration 
on central VP release. 
Steroids could affect peptide synthesis and release by several 
different mechanisms. Since VP content of BNST projections 
appears to depend on the aromatization of testosterone to es- 
tradiol (De Vries et al., 1986), and VP-immunoreactive cells 
within the BNST can also be immunostained for estrogen re- 
ceptors (Axelson and Van Leeuwen, 1990), steroids could in- 
fluence synthesis and release by acting directly on the VP cells. 
As yet, no estrogen response element has been identified in the 
VP gene. However, steroids can influence VP cells in a variety 
of ways. In other neuronal systems, for example, steroids can 
rapidly modulate the excitability of cells via changes in ionic 
conductance (Moss and Dudley, 1984; Nabekura et al., 1986; 
Minami et al., 1990). They can modify synaptic inputs by in- 
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fluencing receptor density (Hammer, 1985; De Kloet et al., 1986; 
O’Connor et al., 1988) as well as transmitter biosynthesis (Blum 
et al., 1987; Argente et al., 1990; Chowen et al., 1990). They 
can even influence the number of axodendritic synapses in adult 
animals (Miyakawa and Arai, 1987). Theoretically, these steroid 
effects could independently influence the different processes in- 
volved in VP synthesis and release by BNST neurons, which 
could explain a discrepancy in postcastration decline in VP 
mRNA and peptide levels. 
Slow changes in neuropeptide content following gonadectomy 
are also seen in other neuronal systems. Although we did not 
quantify this, we noted that VP neurons in the medial amygdala 
(MA) showed a similar gradual decline in immunoreactivity as 
VP neurons in the BNST. VP cells in the MA and BNST are 
similar in other respects as well, including size and morphology 
(Caffe and Van Leeuwen, 1983; Van Leeuwen and Caffe, 1983), 
presence of estrogen receptors (Axelson and Van Leeuwen, 1990), 
sex differences in projections (De Vries and Al-Shamma, 1990), 
and response to castration (De Vries et al., 1986). One might 
therefore predict that the rate of postcastration decline in VP 
mRNA levels in MA cells and BNST cells is also similar. 
A gradual decline following castration has also been reported 
for the neuropeptide content of cholecystokinin (CCK) and sub- 
stance P cells and fibers in the medial preoptic nucleus (MPN), 
BNST, and MA of the rat and hamster (Swann and Newman, 
1987; Malsbury and Nance, 1989). In male rats, CCK cells in 
the MA, BNST, and preoptic area show a postcastration de- 
crease in CCK content that lasts for more than 2 weeks and is 
restored by testosterone treatment (Simerly and Swanson, 1987). 
The cells in the MA and BNST may be the source of CCK fibers 
in the MPN, which gradually lose their immunoreactivity over 
a period of 8 weeks following castration (Malsbury and Nance, 
1989). Although there are no data available on the postcastration 
decline in CCK mRNA levels in males, CCK mRNA levels in 
females vary across the estrous cycle (Simerly et al., 1988), which 
suggests that CCK cells may also respond within a day to changes 
in gonadal steroid levels in males. Conversely, the rate of change 
in VP mRNA we have observed after castration in males would 
allow for changes in VP mRNA across the estrous cycle as well. 
In conclusion, we have observed that the number of VP- 
expressing cells in the BNST declines more rapidly following 
castration than the number of VP-immunoreactive neurons. 
This difference in time course cannot be attributed to colchicine 
pretreatment and may reflect the delay between VP gene ex- 
pression and the production and processing of VP precursor 
molecules. 
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